A Review on Chitosan-Based Nanovaccines Against Newcastle Disease in Poultry
Authors:
- MuqadasMUMuqadas
- Rao Zahid AbbasRARao Zahid Abbas
Open Access
- 1 January 2026
- journal article
- review article
- Published by Walter de Gruyter GmbH in Annals of Animal Science
- Vol. 26 (1) , 107-116
Abstract
Newcastle disease (ND) is a common viral disease of poultry birds that causes huge economic losses in the poultry industry. Sudden outbreaks of ND can cause up to 100% mortality in the flock before showing major clinical signs of the disease. There is no effective treatment for this disease till to date, so its control depends upon vaccination. Currently available vaccines have some issues with delivery and efficacy, so research is being done to find suitable adjuvants for vaccination. Among several adjuvants being tried, nanoparticles (NPs), especially organic NPs, are gaining importance. Chitosan is an organic natural compound, and its NPs are favorable natural biopolymers because of non-toxic, biodegradable, and bioactive properties. Mucosal chitosan-based vaccines are being proven to effectively control the disease as these are potential mucosal adjuvants and cause sustained release of the antigens that can enhance immunity levels. Researchers incorporated free amino and carboxyl groups to address the solubility issues of chitosan and enhance its solubility. These modifications tremendously increase the application of chitosan NPs as vaccine delivery agents. Research indicates that chitosan-derived nanoparticles when loaded with Newcastle disease virus (NDV), whole or a subunit, produce approximately complete immunity by producing cell-mediated and humoral immunity. This review highlights that chitosan-based NPs are potential adjuvants that resolve the problems related to currently available vaccines.Keywords
This publication has 91 references indexed in Scilit:
- Use of Metallic Nanoparticles Against Eimeria—the Coccidiosis-Causing Agents: A Comprehensive ReviewBiological Trace Element Research, 2024
- A clinical perspective of chitosan nanoparticles for infectious disease managementPolymer Bulletin, 2023
- Newcastle Disease Virus2023
- Antiviral Potency of Chitosan, Its Derivatives, and Nanocomposites2022
- Molecular modifications, biological activities, and applications of chitosan and derivatives: A recent updateChirality, 2022
- Evaluation of adjuvant activity of Astragaloside VII and its combination with different immunostimulating agents in Newcastle Disease vaccineBiologicals, 2021
- Current state of chitin purification and chitosan production from insectsJournal of Chemical Technology & Biotechnology, 2020
- Nanoparticle-based vaccines2020
- Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacyApplied Microbiology and Biotechnology, 2019
- Biology and function of adipose tissue macrophages, dendritic cells and B cellsAtherosclerosis, 2018